Taken together, these data unequivocally document that ablation of NFAT2 expression in the B cell compartment of TCL1 transgenic mice leads to transformation of CLL to an aggressive form of B cell lymphoma. The gene discussed is NFATC1; the disease is B-cell chronic lymphocytic leukemia.